DME
02.23.21
Asclepix Therapeutics Partners With Notal Vision on Home OCT Remote Monitoring in DME and AMD Clinical TrialsSource: Asclepix Therapeutics
02.16.21
Kodiak Sciences Announces 1-Year Data from Ongoing Phase 1b Study of KSI-301 in Patients with Retinal Vascular DiseasesSource: Kodiak Sciences
01.07.21
Adverum Biotechnologies Announces New GMP Gene Therapy Manufacturing FacilitySource: Adverum Biotechnologies
01.05.21
AsclepiX Therapeutics Doses First Patient in Phase 1/2a Trial of AXT107 Intravitreal Self-Forming Gel Depot Peptide for DMESource: AsclepiX Therapeutics
12.15.20
Novartis Reports Positive Topline Results From Second Phase 3 Trial of Beovu in Patients With DMESource: Novartis
11.12.20
Kodiak Sciences Announces Presentation of KSI-301 Phase 1b Clinical Study Data Focused on DME at AAO 2020 Virtual MeetingSource: Kodiak Sciences
11.09.20
Oxurion NV Confirms New Patents for THR-687 Issued by European and US Patent OfficesSource: Oxurion